Plasma dolutegravir exposure testing to identify people with HIV at highest risk for dolutegravir resistance (ITREMA-2): a two-centre, prospective implementation study in South Africa.
- DOI
- 10.1016/s2352-3018(26)00144-x
- Published
- 2026 Sep 2
- Container
- The lancet. HIV
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s2352-3018-26-00144-x,
title = {Plasma dolutegravir exposure testing to identify people with HIV at highest risk for dolutegravir resistance (ITREMA-2): a two-centre, prospective implementation study in South Africa.},
author = {Steegen K and Nel J and Smeijsters EH and Umunnakwe CN and Mophiring K and Currin S and Groenestege WMT and Luin MV and Hermans LE and Tempelman HA and Hans L and Jamieson L and Gumede S and Nyatela A and Venter WDF and Nijhuis M and Wensing AMJ},
year = {2026},
journal = {The lancet. HIV},
doi = {10.1016/s2352-3018(26)00144-x},
url = {https://doi.org/10.1016/s2352-3018(26)00144-x}
}RIS
TY - JOUR TI - Plasma dolutegravir exposure testing to identify people with HIV at highest risk for dolutegravir resistance (ITREMA-2): a two-centre, prospective implementation study in South Africa. AU - Steegen K AU - Nel J AU - Smeijsters EH AU - Umunnakwe CN AU - Mophiring K AU - Currin S AU - Groenestege WMT AU - Luin MV AU - Hermans LE AU - Tempelman HA AU - Hans L AU - Jamieson L AU - Gumede S AU - Nyatela A AU - Venter WDF AU - Nijhuis M AU - Wensing AMJ PY - 2026 JO - The lancet. HIV DO - 10.1016/s2352-3018(26)00144-x UR - https://doi.org/10.1016/s2352-3018(26)00144-x ER -
APA
K, S., J, N., EH, S., CN, U., K, M., S, C., WMT, G., MV, L., LE, H., HA, T., L, H., L, J., S, G., A, N., WDF, V., M, N., & AMJ, W. (2026). Plasma dolutegravir exposure testing to identify people with HIV at highest risk for dolutegravir resistance (ITREMA-2): a two-centre, prospective implementation study in South Africa.. The lancet. HIV. https://doi.org/10.1016/s2352-3018(26)00144-x
Source records
- pubmed · retrieved 2026-09-26T02:18:16.967Z